CXCL9 as a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients

CXCL9 as a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients

Background: This study was performed to evaluate the value of inflammatory biomarkers in predicting the prognosis of early-stage (stage IA-IIB) lung adenocarcinoma.Methods: Ten inflammatory biomarkers were tested with a Luminex bead-based assay in early-stage lung adenocarcinoma patients who underwe...

Full description

Bibliographic Details
Main Authors: Yanwei Zhang, Beibei Sun, Minjuan Hu, Yuqing Lou, Jun Lu, Xueyan Zhang, Huimin Wang, Jialin Qian, Tianqing Chu, Baohui Han
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-06-01
Series:Frontiers in Oncology
Subjects:
CXCL9
inflammation
early stage
lung adenocarcinoma
prognosis
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01049/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.01049/full

Similar Items